Page last updated: 2024-09-03

y 27632 and pyridoxal phosphate

y 27632 has been researched along with pyridoxal phosphate in 1 studies

Compound Research Comparison

Studies
(y 27632)
Trials
(y 27632)
Recent Studies (post-2010)
(y 27632)
Studies
(pyridoxal phosphate)
Trials
(pyridoxal phosphate)
Recent Studies (post-2010) (pyridoxal phosphate)
1,92438916,511140860

Protein Interaction Comparison

ProteinTaxonomyy 27632 (IC50)pyridoxal phosphate (IC50)
P2X purinoceptor 1Homo sapiens (human)10

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, M; Kagota, S; Kubota, Y; Kunitomo, M; Nakamura, K; Nejime, N; Shinozuka, K; Takahashi, K; Tanaka, N; Yudo, K1

Other Studies

1 other study(ies) available for y 27632 and pyridoxal phosphate

ArticleYear
Myosin light chain kinase and Rho-kinase participate in P2Y receptor-mediated acceleration of permeability through the endothelial cell layer.
    The Journal of pharmacy and pharmacology, 2005, Volume: 57, Issue:3

    Topics: Adenosine Triphosphate; Amides; Azepines; Cell Membrane Permeability; Chromatography, High Pressure Liquid; Dextrans; Endothelial Cells; Endothelium, Vascular; Fluorescein-5-isothiocyanate; Humans; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Myosin-Light-Chain Kinase; Protein Serine-Threonine Kinases; Pyridines; Pyridoxal Phosphate; Receptors, Purinergic P2; rho-Associated Kinases; Thionucleotides

2005